Jerini is a pharmaceutical company based in Berlin, Germany. Shire Limited's German wholly-owned indirect subsidiary Shire Deutschland Investments GmbH currently holds 100 percent of Jerini’s shares. Jerini is a subsidiary of Shire plc and a member of the Shire group of companies.